Breaking Finance News

Zacks Investment Research disclosed Zoetis Inc (NYSE:ZTS), boosting its price target to $56.00 earlier today

Having a price of $50.38, Zoetis Inc (NYSE:ZTS) traded -3.19% lower on the day. With the last stock price up -1.80% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.03% over the same period. ZTS has recorded a 50-day average of $50.03 and a two hundred day average of $49.67. Trade Volume was down over the average, with 1,674,193 shares of ZTS changing hands under the typical 3,651,210

Reporting a potential upside of 0.11%, Zacks Investment Research upped the price target of Zoetis Inc (NYSE:ZTS) to $56.00

Recent Performance Chart

Zoetis Inc (NYSE:ZTS)

Zoetis Inc has PE ratio of 35.17 with a one year low of $38.26 and a one year high of $53.14 and has a market capitalization of $0.

A total of 10 equity analysts have released a ratings update on ZTS. zero equity analysts rating the company a strong buy, zero brokers rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 firms rating the stock a sell with a consensus target price of $52.70.

About Zoetis Inc (NYSE:ZTS)

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.